(15 APR 2024) Advance in Gene Therapy Approaches to Treat Skeletal Diseases
No. 81 643 2024-04-09
(2024, Spring) In-Depth characterization of antigen-specific T cells by mass cytometry
No. 80 690 2024-03-28
(2024, Spring) Single-cell transcriptome analysis of tumor and non-tumor diseases
No. 79 663 2024-03-21
(2024, Spring) Role of AI in computer vision & disease diagnosis: automatic segmentation
No. 78 749 2024-03-14
(2024, Spring) Modeling hematopoietic disease with human pluripotent stem cells
No. 77 749 2024-03-08
(2024, Spring) Advancing non-invasive neuromodulation
No. 76 715 2024-02-28
(2023, Fall) Enhancing tumor microenvironment using orally available macromolecules
No. 75 730 2023-11-30
(2023, Fall) Molecular architecture of the Gαi-bound TRPC5 ion channel
No. 74 796 2023-11-20
(2023, Fall) Harnessing Chemical Biology Approaches for Targeted RNA and Protein Degradation
No. 73 719 2023-11-15
(2023, Fall) Brain Plasticity & Neurodevelopmental Disorders
No. 72 711 2023-11-08
(1 NOV 2023) Leveraging tumor-specific T cell responses for cancer immunotherapy
No. 71 750 2023-11-01
(2023, Fall) Nanoparticles for messenger RNA delivery : Reaching beyond the Liver
No. 70 628 2023-11-01
(2023, Fall) Social determinants of health, epigenetic biomarkers, and health outcomes
No. 69 622 2023-10-24
(2023, Fall) Understanding B cell biology for rationale vaccine design “from empiricism to rationalism”
No. 68 643 2023-10-18
(2023, Fall) A CNN Based Diagnostic Model Using Chest X-Rays: A Multistage Multiclass Isolated and Developed Transfer Learning Framework
No. 67 719 2023-10-05
(2023, Fall) Development of Muscle-Enhancing Therapeutics Targeting mTORC1
No. 66 641 2023-10-04
(2023, Fall) Digital Healthcare and Diabetes Mellitus
No. 65 674 2023-09-27
(19 SEP 2023) A Gastrointestinal type 2 immune circuit controls mammalian adaptation to dietary chitin
No. 64 690 2023-09-18
(2023, Fall) Biophysical Characterization of Non-covalent Amyloid Protein Complexes
No. 63 689 2023-09-18
(2023, Fall) Towards novel therapeutics against SARS-CoV-2
No. 62 750 2023-08-31